vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与先锋自然资源公司（PR）财务数据对比。点击上方公司名可切换其他公司
先锋自然资源公司的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.6倍（$1.2B vs $749.2M），先锋自然资源公司净利率更高（29.0% vs 3.6%，领先25.4%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs -9.8%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs -3.0%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
先锋自然资源公司总部位于美国得克萨斯州欧文市，主要从事油气勘探业务，运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块，是该区域最大的土地权益持有方，2024年5月被埃克森美孚收购。
CLOV vs PR — 直观对比
营收规模更大
PR
是对方的1.6倍
$749.2M
营收增速更快
CLOV
高出71.8%
-9.8%
净利率更高
PR
高出25.4%
3.6%
两年增速更快
CLOV
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $1.2B |
| 净利润 | $27.3M | $339.5M |
| 毛利率 | — | — |
| 营业利润率 | 3.6% | 23.1% |
| 净利率 | 3.6% | 29.0% |
| 营收同比 | 62.0% | -9.8% |
| 净利润同比 | — | 56.7% |
| 每股收益（稀释后） | $0.05 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVPR
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | $1.2B | ||
| Q3 25 | $496.6M | $1.3B | ||
| Q2 25 | $477.6M | $1.2B | ||
| Q1 25 | $462.3M | $1.4B | ||
| Q4 24 | $337.0M | $1.3B | ||
| Q3 24 | $331.0M | $1.2B | ||
| Q2 24 | $356.3M | $1.2B |
净利润CLOVPR
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $339.5M | ||
| Q3 25 | $-24.4M | $59.2M | ||
| Q2 25 | $-10.6M | $207.1M | ||
| Q1 25 | $-1.3M | $329.3M | ||
| Q4 24 | $-22.1M | $216.7M | ||
| Q3 24 | $-9.2M | $386.4M | ||
| Q2 24 | $7.4M | $235.1M |
毛利率CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — |
营业利润率CLOVPR
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 23.1% | ||
| Q3 25 | -4.9% | 29.6% | ||
| Q2 25 | -2.2% | 24.8% | ||
| Q1 25 | -0.3% | 36.6% | ||
| Q4 24 | -6.4% | 32.8% | ||
| Q3 24 | -2.7% | 32.5% | ||
| Q2 24 | 2.0% | 36.5% |
净利率CLOVPR
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 29.0% | ||
| Q3 25 | -4.9% | 4.5% | ||
| Q2 25 | -2.2% | 17.3% | ||
| Q1 25 | -0.3% | 23.9% | ||
| Q4 24 | -6.6% | 16.7% | ||
| Q3 24 | -2.8% | 31.8% | ||
| Q2 24 | 2.1% | 18.9% |
每股收益（稀释后）CLOVPR
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $0.48 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.28 | ||
| Q1 25 | — | $0.44 | ||
| Q4 24 | — | $0.31 | ||
| Q3 24 | — | $0.53 | ||
| Q2 24 | — | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $153.7M |
| 总债务越低越好 | — | $3.5B |
| 股东权益账面价值 | $339.4M | $10.3B |
| 总资产 | $697.7M | $17.9B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资CLOVPR
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $153.7M | ||
| Q3 25 | — | $111.8M | ||
| Q2 25 | — | $451.0M | ||
| Q1 25 | — | $702.2M | ||
| Q4 24 | $194.5M | $479.3M | ||
| Q3 24 | $288.0M | $272.0M | ||
| Q2 24 | $254.8M | $47.8M |
总债务CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | — | $3.5B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $3.9B |
股东权益CLOVPR
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $10.3B | ||
| Q3 25 | $340.9M | $10.0B | ||
| Q2 25 | $344.2M | $9.5B | ||
| Q1 25 | $336.1M | $9.4B | ||
| Q4 24 | $341.1M | $9.1B | ||
| Q3 24 | $342.2M | $9.0B | ||
| Q2 24 | $324.9M | $8.3B |
总资产CLOVPR
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $17.9B | ||
| Q3 25 | $559.7M | $17.3B | ||
| Q2 25 | $575.0M | $17.5B | ||
| Q1 25 | $583.7M | $17.1B | ||
| Q4 24 | $580.7M | $16.9B | ||
| Q3 24 | $653.0M | $16.6B | ||
| Q2 24 | $674.2M | $15.4B |
负债/权益比CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $904.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.66× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $904.3M | ||
| Q3 25 | $12.1M | $766.5M | ||
| Q2 25 | $5.4M | $1.0B | ||
| Q1 25 | $-16.3M | $898.0M | ||
| Q4 24 | $34.8M | $871.6M | ||
| Q3 24 | $50.0M | $954.4M | ||
| Q2 24 | $44.8M | $938.4M |
自由现金流CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | — | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $49.6M | — | ||
| Q2 24 | $44.4M | — |
自由现金流率CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 12.5% | — |
资本支出强度CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — |
现金转化率CLOVPR
| Q1 26 | — | — | ||
| Q4 25 | — | 2.66× | ||
| Q3 25 | — | 12.94× | ||
| Q2 25 | — | 5.01× | ||
| Q1 25 | — | 2.73× | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 2.47× | ||
| Q2 24 | 6.04× | 3.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |
